Evidence map›Paper›PMID 37497566›Full record

ArticleAllergy2023

Immunoglobulin G4 in eosinophilic esophagitis: Immune complex formation and correlation with disease activity.

Jonathan G Medernach, Rung-Chi Li, Xiao-Yu Zhao, Bocheng Yin, Emily A Noonan, Elaine F Etter, Shyam S Raghavan, Larry C Borish, Jeffrey M Wilson, Barrett H Barnes and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Guideline
  2. Shifting the scope: Moving toward less invasive diagnosis and monitoring of eosinophilic esophagitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Barrier Dysfunction in Eosinophilic Esophagitis.Current gastroenterology reports · 2023
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Jonathan G MedernachDivision of Pediatric Gastroenterology and Hepatology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Rung-Chi LiDivision of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Xiao-Yu ZhaoDepartment of Microbiology, Immunology and Cancer Biology and The Carter Immunology Center, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Bocheng YinDepartment of Microbiology, Immunology and Cancer Biology and The Carter Immunology Center, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Emily A NoonanDivision of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Elaine F EtterDivision of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Shyam S RaghavanDepartment of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Larry C BorishDivision of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Jeffrey M WilsonDivision of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Barrett H BarnesDivision of Pediatric Gastroenterology and Hepatology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Thomas A E Platts-MillsDivision of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID 0000-0002-1263-329X
Sarah E EwaldDepartment of Microbiology, Immunology and Cancer Biology and The Carter Immunology Center, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Bryan G SauerDivision of Gastroenterology and Hepatology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Emily C McGowanDivision of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID 0000-0003-2621-283X
University of Virginia · USCarter Center · USJohns Hopkins University · US

Funding

The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve HealthUL1TR003015 · NCATS · UNIVERSITY OF VIRGINIA · PI BROWN, DONALD E, JOHNSTON, KAREN C. · 2019 to 2023
$20.3M
Clinical response to rhinovirus challenge in human asthmaticsU01AI123337 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2016 to 2020
$3.6M
Innate Inflammatory Control of CachexiaR35GM138381 · NIGMS · UNIVERSITY OF VIRGINIA · PI Sarah E. Ewald · 2020 to 2026
$2.9M
Dietary Methyl Donors and Food Allergy Risk in the United StatesK23AI123596 · NIAID · UNIVERSITY OF VIRGINIA · PI MCGOWAN, EMILY CLARKE · 2017 to 2020
$767k
Improving Biomaterial Implant Tolerance with Damage-Associated Molecular Pathway (DAMP) Molecule AttachmentR21EB028971 · NIBIB · UNIVERSITY OF VIRGINIA · PI EWALD, SARAH E., GRIFFIN, DONALD RICHIERI · 2020 to 2022
$634k
Proteomic interrogation of the parasite vacuole using autoSTOMPR21AI156153 · NIAID · UNIVERSITY OF VIRGINIA · PI EWALD, SARAH E. · 2021 to 2022
$444k
IgE-Independent Mast Cell Activation by Food-Derived Peptides in Eosinophilic Esophagitis (EoE)R21AI151497 · NIAID · UNIVERSITY OF VIRGINIA · PI MCGOWAN, EMILY CLARKE · 2020 to 2021
$444k
Protracted clinical and inflammatory response to rhinovirus challenge in human asthmaticsR56AI158519 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2022 to 2022
$323k
NCATS NIH HHS UL1 TR003015NIAID NIH HHS K23 AI123596NIAID NIH HHS R21 AI151497NIAID NIH HHS R21 AI156153NIAID NIH HHS R56 AI158519NIAID NIH HHS U01 AI123337NIBIB NIH HHS R21 EB028971NIBIB NIH HHS R21EB028971NIGMS NIH HHS R35 GM138381NIH HHS R21AI151497NIH HHS R35GM138381NIH HHS R56AI158519NIH HHS UL1TR003015NIH HHS UO1AI123337
6 · The paper itself

Abstract

backgroundRecent studies have shown deposition of immunoglobulin G4 (IgG4) and food proteins in the esophageal mucosa of eosinophilic esophagitis (EoE) patients. Our aims were to assess whether co-localization of IgG4 and major cow's milk proteins (CMPs) was associated with EoE disease activity and to investigate the proteins enriched in proximity to IgG4 deposits.

methodsThis study included adult subjects with EoE (n = 13) and non-EoE controls (n = 5). Esophageal biopsies were immunofluorescence stained for IgG4 and CMPs. Co-localization in paired samples from active disease and remission was assessed and compared to controls. The proteome surrounding IgG4 deposits was evaluated by the novel technique, AutoSTOMP. IgG4-food protein interactions were confirmed with co-immunoprecipitation and mass spectrometry.

resultsIgG4-CMP co-localization was higher in the active EoE group compared to paired remission samples (Bos d 4, p = .02; Bos d 5, p = .002; Bos d 8, p = .002). Co-localization was also significantly higher in the active EoE group compared to non-EoE controls (Bos d 4, p = .0013; Bos d 5, p = .0007; Bos d 8, p = .0013). AutoSTOMP identified eosinophil-derived proteins (PRG 2 and 3, EPX, RNASE3) and calpain-14 in IgG4-enriched areas. Co-immunoprecipitation and mass spectrometry confirmed IgG4 binding to multiple food allergens.

conclusionThese findings further contribute to the understanding of the interaction of IgG4 with food antigens as it relates to EoE disease activity. These data strongly suggest the immune complex formation of IgG4 and major cow's milk proteins. These immune complexes may have a potential role in the pathophysiology of EoE by contributing to eosinophil activation and disease progression.

Indexed as

Eosinophilic EsophagitisAdultAllergensAnimalsAntigen-Antibody ComplexCattleFemaleHumansImmunoglobulin GMilk ProteinsAllergensAntigen-Antibody ComplexImmunoglobulin GMilk Proteinseosinophilic esophagitisimmunoglobulin G4

Identifiers

PMID37497566
PMCPMC11976675
OpenAlexW4385294474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.